Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi Core MSCI China A Swap UCITS ETF Dist
C024 · LU2572256746 · class UCITS ETF Dist · USD · domicile Luxembourg
Equity · ChinaSFDR art. 6
Index tracked: MSCI China A Net Total Return USD Index
- TER
- 0.25%+ trans. 0.00%
- Fund size
- 451 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Distributingannual
Launch 10 Mar 2023 · costs from the KID as of 2 Sept 2026 · 116 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 8 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of MSCI China A Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a free float-adjusted capitalisation-weighted index that is representative of exposure to the performance mid-cap and large-cap A shares. A shares are the shares of companies…
Performance since series start (in euro) — base 100
10 Mar 2023 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +16.4% |
| 3 years | +42.4% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +25.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 18.90% | 19.11% | — |
| Max drawdown | −10.51% | −19.03% | — |
| Sharpe | 0.62 | 0.55 | — |
| Sortino | 0.89 | 0.81 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · C024 · LU25722567461
RebalixC024 · LU2572256746 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +31.02% | +26.48% | +4.54% |
| 2024 | +13.99% | +11.70% | +2.29% |
Distributions · per share, in USD
Frequency: annual · last 12 months: 3.43 USD (1.75% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 3.43 | +2.42% |
| 2024 | 1 | 3.18 | +2.50% |
| 2023 | 1 | 2.45 | — |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 116 securities · top-10 weight = 42.0%
| Top holdings | Weight |
|---|---|
| 6.9% | |
| 6.1% | |
| 5.8% | |
| 5.3% | |
| 3.7% | |
| 3.2% | |
| 3.0% | |
| 3.0% | |
| 2.6% | |
| 2.5% |
Listing venues
ESMA register (FIRDS) and official exchange lists
C024 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 17 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2572256746
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2572256746
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · C024 · LU25722567462